Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arcturus Therapeutics Ltd (NASDAQ:ARCT)

10.01
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
5.81
Today|||52-Week Range
18.04
-31.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization8.0K31.0K51.0K61.0K
 
 
 
 
 
 
Operating ExpensesGross Income-8.0K-31.0K-51.0K-61.0K
 
 
 
 
 
General Expenses10.3M32.0M18.7M25.1M
 
 
 
 
 
Other Operating Expenses0.001.1M935.0K0.00
 
 
 
Research And Development7.1M25.1M13.5M18.4M
 
 
 
 
 
Total Operating Expenses10.3M33.1M19.7M25.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.3M-33.1M-19.7M-25.2M
 
 
 
 
 
Interest Expense On Debt203.0K10.0K7.0K19.0K
 
 
 
 
 
Other Expenses-16.0K0.00-31.0K-142.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.5M-32.9M-19.4M-24.5M
 
 
 
 
 
Income Taxes-61.0K-17.0K-51.0K-73.0K
 
 
 
 
 
Net Income-10.5M-32.8M-19.4M-24.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.2M13.7M21.6M27.6M
 
 
 
 
 
Shares To Calculate EPS Diluted10.2M13.7M21.6M27.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.04-$2.40-$0.90-$0.89
 
 
 
 
 
EPS Diluted-$1.04-$2.40-$0.90-$0.89